Css LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $742,976 - $835,848	2,600 Added 11.02%	26,200 $7.57 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $5.26 Million - $6.55 Million	-22,400 Reduced 48.7%	23,600 $6.65 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $10.2 Million - $12 Million	45,900 Added 45900.0%	46,000 $12 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $35,402 - $44,690	-200 Reduced 66.67%	100 $22,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $56,247 - $66,330	300 New	300 $60,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $563,700 - $739,500	-2,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $499,425 - $619,525	2,500 New	2,500 $595,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.